Madrigal Pharmaceuticals Director Friedman Sells Shares, Buys 24,520

martes, 13 de enero de 2026, 4:38 pm ET1 min de lectura
MDGL--

Madrigal Pharmaceuticals Inc. (MDGL) has announced that Director Friedman Paul A. has engaged in various share transactions on January 9, 2026. Specifically, he has sold a total of 148 shares at $535.29/share, 473 shares at $536.02/share, 487 shares at $536.88/share, 80 shares at $537.85/share, and 480 shares at $539.23/share. Additionally, he has sold 600 shares at $540.36/share, 1345 shares at $514.68/share, 1996 shares at $515.81/share, 766 shares at $516.84/share, 2450 shares at $517.86/share, and 1363 shares at $518.68/share. Furthermore, he has sold 846 shares at $519.88/share, 681 shares at $521.03/share, 840 shares at $521.98/share, 970 shares at $523/share, 1199 shares at $524.1/share, and 2432 shares at $525.05/share. In contrast, he has purchased 24,520 shares at $15.8/share and sold 1480 shares at $511.98/share, 1094 shares at $513.11/share, and 280 shares at $551.24/share. Other transactions include the sale of 40 shares at $545.79/share, 575 shares at $528.18/share, and 691 shares at $529.17/share. Director Taub Rebecca has also sold 1335 shares at $524.06/share and purchased 240 shares at $15.8/share.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios